Interestingly, inhibitors of Syk, Btk or PI3K-δ [17] also impair CLL cell migration induced by pro-survival chemokines such as CXCL12 upon binding to its cognate receptor CXCR4 [16]. The gene discussed is BTK; the disease is B-cell chronic lymphocytic leukemia.